Historial de carrera de Da Qing Cai
Antiguos cargos conocidos de Da Qing Cai.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Director/Miembro de la Junta | 20/08/2020 | 23/03/2023 |
| Independent Dir/Board Member | 20/08/2020 | 23/03/2023 | |
| BIONANO GENOMICS, INC. | Director/Miembro de la Junta | 01/08/2018 | 01/08/2019 |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Director/Miembro de la Junta | 01/06/2016 | 01/03/2019 |
| BERRY GENOMICS CO.,LTD | Director/Miembro de la Junta | 01/07/2017 | 01/04/2018 |
Formación de Da Qing Cai.
| University of Science & Technology of China | Undergraduate Degree |
| Yale University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Estadísticas
Internacional
| China | 5 |
| Estados Unidos | 4 |
Operativa
| Director/Board Member | 4 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BERRY GENOMICS CO.,LTD | Health Technology |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| BIONANO GENOMICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Bolsa de valores
- Insiders
- Da Qing Cai
- Experiencia
